Editorial Commentary
The “ What's Happening” section has been instrumental in increasing awareness about new developments in laboratory diagnostics for the treatment of patients requiring transfusion. We have achieved this by inviting experts in their fields to share their experience on how to better diagnose and treat patients using more personalized precision transfusion approaches. By working with some willing experts we hope to better understand how to provide a service to our readers and will pursue the lessons learned as we move forward. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 20, 2023 Category: Hematology Authors: Jerard Seghatchian Source Type: research
Therapeutic Apheresis and Nephrologist: New and old aspects
The clinical efficacy of therapeutic apheresis is still controversial. We undertook a retrospective review of apheresis treatment to ascertain its safety and efficacy. The therapeutic apheresis consists of a continuously improving therapeutic method for diseases with high mortality and morbidity, especially in cases with poor outcome by using current medications. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 17, 2023 Category: Hematology Authors: Ioannis Griveas Source Type: research
Therapeutical apheresis and nephrologist: New and old aspects
The clinical efficacy of therapeutic apheresis is still controversial. We undertook a retrospective review of apheresis treatment to ascertain its safety and efficacy. The therapeutic apheresis consists of a continuously improving therapeutic method for diseases with high mortality and morbidity, especially in cases with poor outcome by using current medications. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 17, 2023 Category: Hematology Authors: Ioannis Griveas Source Type: research
Therapeutical Apheresis and Nephrologist: New and old aspects.
The clinical efficacy of therapeutic apheresis is still controversial. We undertook a retrospective review of apheresis treatment to ascertain its safety and efficacy. The therapeutic apheresis consists of a continuously improving therapeutic method for diseases with high mortality and morbidity, especially in cases with poor outcome by using current medications. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 17, 2023 Category: Hematology Authors: Ioannis Griveas Source Type: research
Therapeutic Apheresis in Renal Transplantation: an update
Therapeutic apheresis (TA) plays a significant role in various aspects of renal transplantation. It has been a necessary preconditioning component in ABO incompatible kidney transplants and an important modality in the removal of anti-human leukocyte antigen (HLA) antibodies both in the context of desensitization protocols that have been developed to allow highly sensitized kidney transplant candidates to be successfully transplanted and as treatment of antibody mediated rejection episodes post transplantation. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 16, 2023 Category: Hematology Authors: Melexopoulou Christina, Filiopoulos Vassilis, Marinaki Smaragdi Source Type: research
Use of therapeutic apheresis methods during pregnancy
This review will focus on the current application of TA in pregnancy and possible aspects for future studies. It seems that scientific interest and field for further research in pregnancy is lately focused in specific removal of pathogens implicated in the physiologic mechanism of pre-eclampsia/HELLP syndrome as well as recurrent pregnancy failure. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 15, 2023 Category: Hematology Authors: Paraskevi Tseke, Petros Tsekes, Ioannis Griveas Source Type: research
Plasma Exchange in patients with ANCA-associated Vasculitis
ANCA-associated Vasculitides (AAV) are characterized by small vessel necrotizing inflammation and can present with multisystem organ involvement, including organ/life threatening manifestations of rapidly progressive glomerulonephritis and diffuse alveolar haemorrhage, where immediate and aggressive intervention is needed to prevent further organ damage. Although, the rationale of plasma exchange (PLEX) in AAV is strong, through removing the pathogenic ANCAs; target either myeloperoxidase (MPO) or proteinase 3 (PR3), and other inflammatory molecules, especially in the initiation when the immunosuppressive treatment is no s...
Source: Transfusion and Apheresis Science - November 15, 2023 Category: Hematology Authors: Aglaia Chalkia, Dimitrios Petras Source Type: research
Use of therapeutical apheresis methods during pregnancy
This review will focus on the current application of TA in pregnancy and possible aspects for future studies. It seems that scientific interest and field for further research in pregnancy is lately focused in specific removal of pathogens implicated in the physiologic mechanism of pre-eclampsia/HELLP syndrome as well as recurrent pregnancy failure. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 15, 2023 Category: Hematology Authors: Paraskevi Tseke, Petros Tsekes, Ioannis Griveas Source Type: research
Stem Cells mobilization and collection in allogeneic related and unrelated donors: a single center experience with focus on plerixafor
Poor CD34 + cells mobilization in allogeneic donors could affect transplant outcome. In a subgroup of patient mobilization with granulocyte colony-stimulating factor (G-CSF) alone is unsatisfactory, and Plerixafor could be used to enhance CD34 + cells release from bone marrow niche. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 1, 2023 Category: Hematology Authors: Chiara Marcon, Antonella Bertone, Sara Mauro, Rosalba Mestroni, Giulia Battaglia, Umberto Pizzano, Gabriele Facchin, Maria De Martino, Miriam Isola, Francesca Patriarca, Giovanni Barillari, Chiara Savignano Tags: Review Source Type: research
Stem Cell mobilization and collection in allogeneic related and unrelated donors: a single center experience with focus on plerixafor.
Poor CD34+ mobilization in allogeneic donors could affect transplant outcome. In a subgroup of patient mobilization with granulocyte colony-stimulating factor (G-CSF) alone is unsatisfactory, and Plerixafor could be used to enhance CD34+ release from bone marrow niche. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 1, 2023 Category: Hematology Authors: Marcon Chiara, Bertone Antonella, Mauro Sara, Mestroni Rosalba, Battaglia Giulia, Pizzano Umberto, Facchin Gabriele, De Martino Maria, Isola Miriam, Patriarca Francesca, Barillari Giovanni, Savignano Chiara Tags: Review Source Type: research
Therapeutic Apheresis in Renal Transplantation: an update
Therapeutic apheresis (TA) plays a significant role in various aspects of renal transplantation. It has been a necessary preconditioning component in ABO incompatible kidney transplants and an important modality in the removal of anti-human leukocyte antigen (HLA) antibodies both in the context of desensitization protocols that have been developed to allow highly sensitized kidney transplant candidates to be successfully transplanted and as treatment of antibody mediated rejection episodes post transplantation. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - November 1, 2023 Category: Hematology Authors: Melexopoulou Christina, Filiopoulos Vassilis, Marinaki Smaragdi Source Type: research
Guest editor ’s bio
Francesco Lanza is professor of Hematology (University Medical School of Bologna- Alma Mater Studiorum), head of the Hematology and Phase 1 trial Unit in Ravenna (Italy), director of the Stem cell Transplant Network in the Romagna Region. He is Senior Editor of Transfusion and Apheresis Science, Associate Editor for the International Journal Cytometry part B, and Cancers. He serves as editorial board member for more than 10 International Journals. He acts as Subcommittee chair of the Acute Leukemia Working Party of the European Transplantation Society EBMT (2018-today), president of the Italian Society for Apheresis and Ma...
Source: Transfusion and Apheresis Science - October 31, 2023 Category: Hematology Authors: Francesco Lanza Source Type: research
Apheresis Practices in India: Progress and Future Scope
The development of apheresis facilities in India has been a gradual but steadily advancing process. This progress is most evident in three key aspects: (a) the widening scope of indications for which apheresis procedures are employed, (b) increased availability of advanced equipment, and (c) availability of the trained personnel for carrying out apheresis procedures. For a comprehensive understanding of this evolution, we have categorized this journey into different time durations, each marked by specific developments and milestones. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - October 31, 2023 Category: Hematology Authors: Gopal Kumar Patidar, Hem Chandra Pandey, Rahul Chaurasia Source Type: research
“Guest Editor’s Bio”
Francesco Lanza is professor of Hematology (University Medical School of Bologna- Alma Mater Studiorum), head of the Hematology and Phase 1 trial Unit in Ravenna (Italy), director of the Stem cell Transplant Network in the Romagna Region. He is Senior Editor of Transfusion and Apheresis Science, Associate Editor for the International Journal Cytometry part B, and Cancers. He serves as editorial board member for more than 10 International Journals. He acts as Subcommittee chair of the Acute Leukemia Working Party of the European Transplantation Society EBMT (2018-today), president of the Italian Society for Apheresis and Ma...
Source: Transfusion and Apheresis Science - October 31, 2023 Category: Hematology Authors: Francesco Lanza Source Type: research
Connectivity in transfusion medicine: challenges, benefits, and goals
In this report, blood center professionals describe how they currently use IT solutions to improve their blood processing methods, the challenges they have, and how they envision IT solutions improving transfusion medicine in the future. (Source: Transfusion and Apheresis Science)
Source: Transfusion and Apheresis Science - October 26, 2023 Category: Hematology Authors: Aspen King, Guillem Beltran Arroyos, Nicolas Cellier, Steve Durgacharan, Maria Kerr, Luis Larrea, Marcia Cardoso Tags: Short Report Source Type: research
